As Constellation Brands (STZ) Valuation Rose, Baldwin Investment Management Has Raised by $566,125 Its Position; Hightower Advisors Has Decreased Icon Plc (ICLR) Position by $411,930; Shares Declined

ICON Public Limited Company (NASDAQ:ICLR) Logo

Baldwin Investment Management Llc increased its stake in Constellation Brands Inc (STZ) by 111.36% based on its latest 2019Q1 regulatory filing with the SEC. Baldwin Investment Management Llc bought 3,235 shares as the company’s stock rose 17.29% with the market. The institutional investor held 6,140 shares of the beverages (production and distribution) company at the end of 2019Q1, valued at $1.08M, up from 2,905 at the end of the previous reported quarter. Baldwin Investment Management Llc who had been investing in Constellation Brands Inc for a number of months, seems to be bullish on the $38.27B market cap company. The stock increased 0.98% or $1.93 during the last trading session, reaching $199.6. About 1.20M shares traded. Constellation Brands, Inc. (NYSE:STZ) has declined 7.59% since July 14, 2018 and is downtrending. It has underperformed by 12.02% the S&P500.

Hightower Advisors Llc decreased its stake in Icon Plc (ICLR) by 27.26% based on its latest 2019Q1 regulatory filing with the SEC. Hightower Advisors Llc sold 2,985 shares as the company’s stock declined 3.24% while stock markets rallied. The institutional investor held 7,966 shares of the commercial physical & biological resarch company at the end of 2019Q1, valued at $1.10 million, down from 10,951 at the end of the previous reported quarter. Hightower Advisors Llc who had been investing in Icon Plc for a number of months, seems to be less bullish one the $8.05 billion market cap company. The stock decreased 0.43% or $0.65 during the last trading session, reaching $149.04. About 101,965 shares traded. ICON Public Limited Company (NASDAQ:ICLR) has risen 10.23% since July 14, 2018 and is uptrending. It has outperformed by 5.80% the S&P500. Some Historical ICLR News: 02/05/2018 – Icon 1Q EPS $1.42; 02/05/2018 – ICON 1Q NET REV. $620.1M; 17/04/2018 – ICON Announces Agreement With Intel Allowing Integration of the Intel(R) Pharma Analytics Platform for Clinical Trials; 14/05/2018 – ICON CLINICAL RESEARCH PARTNERSHIP W/ DUPAGE MEDICAL GROUP; 15/05/2018 – Saama Technologies and ICON Commercialization and Outcomes Partner to Unlock the Value of Real World Evidence (RWE); 17/04/2018 – ICON PLC – AGREED ON PRELIMINARY DEAL TERMS WITH INTEL TO ENABLE ICON TO OFFER INTEL PHARMA ANALYTICS PLATFORM FOR USE IN CLINICAL TRIALS

Analysts await ICON Public Limited Company (NASDAQ:ICLR) to report earnings on July, 24. They expect $1.68 EPS, up 11.26% or $0.17 from last year’s $1.51 per share. ICLR’s profit will be $90.68 million for 22.18 P/E if the $1.68 EPS becomes a reality. After $1.63 actual EPS reported by ICON Public Limited Company for the previous quarter, Wall Street now forecasts 3.07% EPS growth.

Hightower Advisors Llc, which manages about $15.08B and $14.97B US Long portfolio, upped its stake in Invesco India Exchg Tred Fd by 24,735 shares to 47,592 shares, valued at $1.20M in 2019Q1, according to the filing. It also increased its holding in Buckeye Partners LP (NYSE:BPL) by 14,463 shares in the quarter, for a total of 70,682 shares, and has risen its stake in Alibaba Group Hldg Ltd (NYSE:BABA).

More notable recent ICON Public Limited Company (NASDAQ:ICLR) news were published by: which released: “Icon Reaches Analyst Target Price – Nasdaq” on July 01, 2019, also with their article: “ICON (ICLR) Q1 2019 Earnings Call Transcript – Motley Fool” published on May 03, 2019, published: “Why Contract Research Organizations Can Be Money-Making Machines for Investors – The Motley Fool” on January 25, 2019. More interesting news about ICON Public Limited Company (NASDAQ:ICLR) were released by: and their article: “MolecularMD is acquired by ICON – GlobeNewswire” published on February 21, 2019 as well as‘s news article titled: “ICLR or HQY: Which Is the Better Value Stock Right Now? – Yahoo Finance” with publication date: April 24, 2019.

Investors sentiment increased to 1.73 in 2019 Q1. Its up 0.70, from 1.03 in 2018Q4. It increased, as 86 investors sold STZ shares while 174 reduced holdings. 143 funds opened positions while 307 raised stakes. 129.74 million shares or 4.11% less from 135.29 million shares in 2018Q4 were reported. North Carolina-based Triangle Secs Wealth Mngmt has invested 0.23% in Constellation Brands, Inc. (NYSE:STZ). Moreover, Fulton Savings Bank Na has 0.07% invested in Constellation Brands, Inc. (NYSE:STZ). Neumann Cap Mgmt Ltd Limited Liability Company has invested 0.48% of its portfolio in Constellation Brands, Inc. (NYSE:STZ). Bartlett & Ltd Liability Company accumulated 3 shares. 2,257 are owned by First Hawaiian Fincl Bank. New England Rech reported 2,575 shares stake. State Of Wisconsin Board reported 241,281 shares. Meag Munich Ergo Kapitalanlagegesellschaft Mbh holds 0.09% in Constellation Brands, Inc. (NYSE:STZ) or 6,367 shares. Cap Advisers invested in 0.01% or 8,906 shares. Peapack Gladstone Fin Corp owns 17,764 shares. Arrow has 8,801 shares. Van Hulzen Asset Lc reported 5,634 shares. Cobblestone Cap Advsrs Lc has invested 0.08% in Constellation Brands, Inc. (NYSE:STZ). Hrt Ltd, New York-based fund reported 3,341 shares. U S Glob Inc stated it has 0.2% of its portfolio in Constellation Brands, Inc. (NYSE:STZ).

Since February 1, 2019, it had 0 insider purchases, and 1 sale for $140,171 activity.

Constellation Brands, Inc. (NYSE:STZ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.